Ab03b87f-figure-01 (Esterified Estrogens And Methyltestosterone Tablet 1)
Esterified Estrogens And Methyltestosterone Tablet
Product Images NDC 51293-640
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Esterified Estrogens And Methyltestosterone (NDC 51293-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eci Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ab03b87f-figure-02 (Esterified Estrogens And Methyltestosterone Tablet 2)
The text is a table presenting the relative and absolute risk observed for different health events in a WHI study of CE/MPA. It compares the results for those who took CE/MPA to those who didn't, including events such as CHD, stroke, breast cancer, and hip fractures. The table also includes the number of events observed for each condition and the absolute risk per 10,000 women-years.*
0.625mg 1.25mg Label (Esterified Estrogens And Methyltestosterone Tablet 3)
This is a medication called "Esterified Estrogens and Methyltestosterone" made by ECI Pharmaceuticals. Each tablet contains a specified amount of the two components. The dosage instructions should be obtained from the package insert. A patient information leaflet is available with each package dispensed. The medication should be stored within a certain temperature range. It is produced by EC| Pharmaceuticals, LLC, with 100 tablets per package. The information was published in September 2020.*
1.25mg 2.5mg Label (Esterified Estrogens And Methyltestosterone Tablet 4)
This is a medication with NDC 51293-640-01 for hormonal replacement therapy containing Esterified Estrogens, USP 25 mg and Methyltestosterone, USP 5mg. The medication is available in tablet form, and the package insert should be consulted for complete prescribing information. Each package includes one patient information leaflet titled "What You Should Know About Estrogens." The medication should be stored between 20° - 25°C (68° - 77°F) with excursions permitted to 15° - 30°C (59° - 86°F). It is manufactured by ECI Pharmaceuticals, LLC in Florida.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
